G2GBio

456160· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩31,600-4.24%

2026-09-18

Financials

Valuation Metrics

G2GBio's Market Cap is ₩5255B. At end of 2025 it was ₩1.1T. Ranked #453 of 2,421 in KR market (top 19%), #160 of 1,640 on KOSDAQ (top 10%), #48 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 21%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	525.49B KRW	KR#453/2,421 Sec#48/231
Revenue	2.22B KRW	KR#2,380/2,421 Sec#213/231
Net Income	-17.58B KRW	KR—/2,421 Sec—/231
Total Assets	235.05B KRW	KR#1,193/2,421 Sec#84/231
Net Assets	139.02B KRW	KR#1,184/2,421 Sec#89/231
Value
P/B	3.78x	KR#2,179/2,421 Sec#177/231
P/S	237.19x	KR#2,403/2,421 Sec#218/231
FCF Yield	-2.71%	KR—/2,421 Sec—/231
Profitability
ROE	-12.65%	KR#1,987/2,421 Sec#151/231
ROA	-7.48%	KR#2,034/2,421 Sec#149/231
Op. Margin	-568.74%	KR#2,370/2,421 Sec#207/231
Revenue Growth	-44.98%	KR#2,277/2,421 Sec#202/231
Financial Health
Debt Ratio	69.08%	KR#1,207/2,421 Sec#146/231
Total Debt	40.82B KRW	KR#1,084/2,421 Sec#75/231
FCF	-14.23B KRW	KR#1,808/2,421 Sec#165/231
Cash	12.07B KRW	KR#1,577/2,421 Sec#132/231
Current Ratio	2.38x	KR#726/2,421 Sec#86/231
Performance
1Y Return	-55.52%	KR#2,144/2,421 Sec#200/231
1M Return	-23.02%	KR#2,322/2,421 Sec#215/231
From 52W High	-74.52%	KR#2,281/2,421 Sec#200/231
1Y MDD	-80.68%	KR#2,308/2,421 Sec#212/231
Trading
Volume	133,960 shares	KR#644/2,421 Sec#55/231
Trading Value	4.28B KRW	KR#397/2,421 Sec#37/231
Foreign Own.	5.69%	KR#768/2,421 Sec#71/231
Per Share
EPS	-1,057 KRW	KR—/2,421 Sec—/231
BPS	8,360 KRW	KR#1,104/2,421 Sec#77/231